Microbes and obesity-interrelationship between infection, adipose tissue and the immune system

Clinical Microbiology and Infection

Volumn 19, Issue 4, 2013, Pages 314-320

  Hegde, V ^a   Dhurandhar, N V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Immune response; Infection; Microbes; Obesity; Virus

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; AVIADENOVIRUS; CELL EXPANSION; CELL PROLIFERATION; DISEASE MODEL; EXTRACELLULAR MATRIX; FIBROBLAST; HELICOBACTER PYLORI; HUMAN ADENOVIRUS; IMMUNE SYSTEM; INFECTION SENSITIVITY; INNATE IMMUNITY; KLEBSIELLA; LIPID DIET; LISTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBESITY; PHAGOCYTE; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW; SELENOMONAS; TISSUE EXPANSION;

EID: 84875501206     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12157     Document Type: Review

References (84)

1. McAllister EJ, Dhurandhar NV, Keith SW et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009; 49: 868-913.
2. Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect Dis 2011; 11: 963-969.
3. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science 1982; 216: 82-85.
4. Pasarica M, Dhurandhar NV. Infectobesity: obesity of infectious origin. Adv Food Nutr Res 2007; 52: 61-102.
5. Cani PD, Amar J, Iglesias MA. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
6. Dart AM, Martin JL, Kay S. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes Relat Metab Disord 2002; 26: 464-468.
7. Goodson JM, Groppo D, Halem S, Carpino E. Is obesity an oral bacterial disease? J Dent Res 2009; 88: 519-523.
8. Arslan E, Atilgan H, Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 2009; 20: 695-697.
9. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
10. Fernandez-Real JM, Ferri MJ, Vendrell J, Ricart W. Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) 2007; 15: 245-252.
11. Lynch JP III, Fishbein M, Echavarria M. Adenovirus. Semin Respir Crit Care Med 2011; 32: 494-511.
12. Mast TC, Kierstead L, Gupta SB et al. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 2010; 28: 950-957.
13. Barouch DH, Kik SV, Weverling GJ et al. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine 2011; 29: 5203-5209.
14. Dhurandhar N, Kulkarni P, Ajinkya S, Sherikar A. Avian adenovirus leading to pathognomonic obesity in chicken. J. Bom Vet College 1990; 2: 131-132.
15. Dhurandhar NV, Kulkarni P, Ajinkya SM, Sherikar A. Effect of adenovirus infection on adiposity in chicken. Vet Microbiol 1992; 31: 101-107.
16. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Association of adenovirus infection with human obesity. Obes Res 1997; 5: 464-469.
17. Wigand R. Age and susceptibility of Swiss mice for mouse adenovirus, strain FL. Arch Virol 1980; 64: 349-357.
18. Dhurandhar NV. Infections and body weight: an emerging relationship? Int J Obes Relat Metab Disord 2002; 26: 745-746.
19. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL. Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 2001; 25: 990-996.
20. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000; 24: 989-996.
21. Pasarica M, Shin AC, Yu M et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006; 14: 1905-1913.
22. Dhurandhar NV, Whigham LD, Abbott DH et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 2002; 132: 3155-3160.
23. Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis 2012; 205: 914-922.
24. Pasarica M, Loiler S, Dhurandhar NV. Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 2008; 153: 2097-2102.
25. Krishnapuram R, Dhurandhar EJ, Dubuisson O et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779-E789.
26. Chida D, Osaka T, Hashimoto O, Iwakura Y. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 2006; 55: 971-977.
27. Butler AA, Kesterson RA, Khong K et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141: 3518-3521.
28. Lang P, van Harmelen V, Ryden M et al. Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS ONE 2008; 3: e1713.
29. Krishnapuram R, Kirk-Ballard H, Zuberi A, Dhurandhar NV. Infectivity period of mice inoculated with human adenoviruses. Lab Anim 2011; 45: 103-108.
30. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2010; 34: 89-93.
31. Na HN, Kim J, Lee HS et al. Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) 2012; 36: 281-285.
32. Trovato GM, Castro A, Tonzuso A et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402-1409.
33. Broderick MP, Hansen CJ, Irvine M et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond) 2010; 34: 302-308.
34. Goossens VJ, de Jager SA, Grauls GE et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) 2011; 19: 220-221.
35. Atkinson RL, Dhurandhar NV, Allison DB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286.
36. Trovato GM, Martines GF, Trovato FM et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535-544.
37. Trovato GM, Martines GF, Garozzo A et al. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184-190.
38. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004; 12: 770-777.
39. Rogers PM, Fusinski KA, Rathod MA et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond) 2008; 32: 397-406.
40. Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity (Silver Spring) 2009; 17: 657-664.
41. Pasarica M, Mashtalir N, McAllister EJ et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008; 26: 969-978.
42. Mancuso P. Obesity and lung inflammation. J Appl Physiol 2010; 108: 722-728.
43. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 2002; 168: 4018-4024.
44. Hsu A, Aronoff DM, Phipps J, Goel D, Mancuso P. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol 2007; 150: 332-339.
45. Wieland CW, Florquin S, Chan ED et al. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 2005; 17: 1399-1408.
46. Ordway D, Henao-Tamayo M, Smith E et al. Animal model of Mycobacterium abscessus lung infection. J Leukoc Biol 2008; 83: 1502-1511.
47. Park S, Rich J, Hanses F, Lee JC. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun 2009; 77: 1008-1014.
48. Ikejima S, Sasaki S, Sashinami H et al. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 2005; 54: 182-189.
49. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007; 137: 1236-1243.
50. + T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009; 126: 268-279.
51. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010; 184: 3127-3133.
52. Huszar D, Lynch CA, Fairchild-Huntress V et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
53. Kennedy AJ, Ellacott KL, King VL, Hasty AH. Mouse models of the metabolic syndrome. Dis Model Mech 2010; 3: 156-166.
54. Dossett LA, Dageforde LA, Swenson BR et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt) 2009; 10: 137-142.
55. Ylostalo P, Suominen-Taipale L, Reunanen A, Knuuttila M. Association between body weight and periodontal infection. J Clin Periodontol 2008; 35: 297-304.
56. Jedrychowski W, Maugeri U, Flak E, Mroz E, Bianchi I. Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland. Public Health 1998; 112: 189-195.
57. Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 2009; 49: 140-147. 147 e1; discussion 147.
58. Olsen MA, Nepple JJ, Riew KD et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008; 90: 62-69.
59. Potapov EV, Loebe M, Anker S et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 2003; 24: 1933-1941.
60. Swenne CL, Lindholm C, Borowiec J, Carlsson M. Surgical-site infections within 60 days of coronary artery by-pass graft surgery. J Hosp Infect 2004; 57: 14-24.
61. Jain S, Chaves SS. Obesity and influenza. Clin Infect Dis 2011; 53: 422-424.
62. Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011; 53: 413-421.
63. Akiyama N, Segawa T, Ida H et al. Bimodal effects of obesity ratio on disease duration of respiratory syncytial virus infection in children. Allergol Int 2011; 60: 305-308.
64. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 17-30.
65. Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med 2012; 33: 35-45.
66. De Rosa V, Procaccini C, Cali G et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26: 241-255.
67. Odegaard JI, Chawla A. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab 2008; 4: 619-626.
68. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009; 6: 399-409.
69. Poglio S, De Toni-Costes F, Arnaud E et al. Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cells 2010; 28: 2065-2072.
70. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
71. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012; 23: 407-415.
72. Krasnodembskaya A, Samarani G, Song Y et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol 2012; 302: L1003-L1013.
73. Mei SH, Haitsma JJ, Dos Santos CC et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047-1057.
74. Caspar-Bauguil S, Cousin B, Galinier A et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 2005; 579: 3487-3492.
75. Saely CH, Geiger K, Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology 2012; 58: 15-23.
76. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 1992; 89: 1006-1013.
77. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000; 275: 24255-24263.
78. Pelton PD, Zhou L, Demarest KT, Burris TP. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun 1999; 261: 456-458.
79. Cousin B, Munoz O, Andre M et al. A role for preadipocytes as macrophage-like cells. FASEB J 1999; 13: 305-312.
80. Cousin B, Andre M, Casteilla L, Penicaud L. Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol 2001; 186: 380-386.
81. Charriere G, Cousin B, Arnaud E et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003; 278: 9850-9855.
82. Van Kaer L, Parekh VV, Wu L. Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol 2012; doi:10.1016/j.it.2012.08.009.
83. Lynch L, Nowak M, Varghese B et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012; 37: 574-587.
84. Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity role of Wnt, tumor necrosis factor-α, and inflammation. Diabetes 2009; 58: 1550-1557.